Hydromorphone 경구제 (품명: 딜리드정2밀리그람 등)
기준 내용
※ 동 고시는 고시 제2017-153호(2017.9.1.)로 삭제되었으며 「[일반원칙] 마약성진통제」로 통합 되었습니다.
기준 내용
허가사항 범위 내에서 투여 시 요양급여를 하며, 비암성통증에는 단기간 사용을 원칙으로 함.
고시 개정 사유
신경블록의 효과가 부족할 경우 마약성 진통제 투여가 필요한 임상현실을 고려하여 급여확대함.
관련문헌 등 7줄
식품의약품안전처 허가사항 Harrison's Principles of Internal Medicine, 19e, 2015. Chapter 18: Pain: Pathophysiology and Management Rang & Dale's Pharmacology, Eighth Edition, 2016. Chapter 42. Analgesic drugs Wall and Melzack's Textbook of Pain, 6e (2013). Chapter 31 Hauser W, et. al, Clinical practice guideline: Long-term opioid use in non-cancer pain.
ICSI(Institute for Clinical Systems Improvement) Assessment and Management of Chronic Pain. Updated November 2013.
Canadian guideline for safe and effective use of opioids for chronic non-cancer pain CDC Guideline for Prescribing Opioids for Chronic Pain (March 18, 2016)
Interagency Guideline on Prescribing Opioids for Pain(Washington State Agency Medical Directors’ Group(AMDG), 3rd Ed. 2015)
Chou R, et. al, The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015 Feb 17;162(4):276-86. doi: 10.7326/M14-2559.
Manchikanti L1 et. al, A systematic review of randomized trials of long-term opioid management for chronic non-cancer pain. Pain Physician. 2011 Mar-Apr;14(2):91-121.
O'Connell NE, et al. Interventions for treating pain and disability in adults with complex regional pain syndrome. Cochrane Database Syst Rev - January 1 Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan. Subject: Analgesics, Narcotics and Narcotic Combination PBAC - Opioid Analgesics: Overview, Drug utilisation sub-committee (DUSC), October 2014
변경 전 고시번호(시행일자)
고시 제2013-127호(2013.9.1.)
출처: 건강보험심사평가원 보험인정기준 고시 고시 제2016-223호(약제) · 심평원 원문 보기. 참고용 정보이며 청구·심사의 최종 판단은 고시 원문과 심평원 기준을 따릅니다.